Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.

Maurel M, Pozo F, Pérez-Gimeno G, Buda S, Sève N, Oroszi B, Hooiveld M, Gomez V, Domegan L, Martínez-Baz I, Ilić M, Carnahan AS, Mihai ME, Martínez A, Goerlitz L, Enouf V, Horváth JK, Dijkstra F, Rodrigues AP, Bennett C, Trobajo-Sanmartín C, Mlinarić I, Latorre-Margalef N, Ivanciuc A, Lopez A, Dürrwald R, Falchi A, Túri G, Meijer A, Melo A, O'Donnell J, Castilla J, Vučina VV, Hagey TS, Lazar M, Kaczmarek M, Bacci S, Kissling E, VEBIS study team

Open source

DOI
10.1111/irv.13243
Published
2024 Jan
Container
Influenza and other respiratory viruses
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/irv.13243,
  title = {Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.},
  author = {Maurel M and Pozo F and Pérez-Gimeno G and Buda S and Sève N and Oroszi B and Hooiveld M and Gomez V and Domegan L and Martínez-Baz I and Ilić M and Carnahan AS and Mihai ME and Martínez A and Goerlitz L and Enouf V and Horváth JK and Dijkstra F and Rodrigues AP and Bennett C and Trobajo-Sanmartín C and Mlinarić I and Latorre-Margalef N and Ivanciuc A and Lopez A and Dürrwald R and Falchi A and Túri G and Meijer A and Melo A and O'Donnell J and Castilla J and Vučina VV and Hagey TS and Lazar M and Kaczmarek M and Bacci S and Kissling E and VEBIS study team},
  year = {2024},
  journal = {Influenza and other respiratory viruses},
  doi = {10.1111/irv.13243},
  url = {https://doi.org/10.1111/irv.13243}
}

RIS

TY  - JOUR
TI  - Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
AU  - Maurel M
AU  - Pozo F
AU  - Pérez-Gimeno G
AU  - Buda S
AU  - Sève N
AU  - Oroszi B
AU  - Hooiveld M
AU  - Gomez V
AU  - Domegan L
AU  - Martínez-Baz I
AU  - Ilić M
AU  - Carnahan AS
AU  - Mihai ME
AU  - Martínez A
AU  - Goerlitz L
AU  - Enouf V
AU  - Horváth JK
AU  - Dijkstra F
AU  - Rodrigues AP
AU  - Bennett C
AU  - Trobajo-Sanmartín C
AU  - Mlinarić I
AU  - Latorre-Margalef N
AU  - Ivanciuc A
AU  - Lopez A
AU  - Dürrwald R
AU  - Falchi A
AU  - Túri G
AU  - Meijer A
AU  - Melo A
AU  - O'Donnell J
AU  - Castilla J
AU  - Vučina VV
AU  - Hagey TS
AU  - Lazar M
AU  - Kaczmarek M
AU  - Bacci S
AU  - Kissling E
AU  - VEBIS study team
PY  - 2024
JO  - Influenza and other respiratory viruses
DO  - 10.1111/irv.13243
UR  - https://doi.org/10.1111/irv.13243
ER  - 

APA

M, M., F, P., G, P., S, B., N, S., B, O., M, H., V, G., L, D., I, M., M, I., AS, C., ME, M., A, M., L, G., V, E., JK, H., F, D., AP, R., C, B., C, T., I, M., N, L., A, I., A, L., R, D., A, F., G, T., A, M., A, M., J, O., J, C., VV, V., TS, H., M, L., M, K., S, B., E, K., & team, V. S. (2024). Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.. Influenza and other respiratory viruses. https://doi.org/10.1111/irv.13243

Source records